CS
ABBV icon

Capital Square’s AbbVie ABBV Stock Holding History

Capital Square’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Sell
1,039
-9
-0.9% -$2K 0.1% 211
2025
Q4 		$239K Sell
1,048
-257
-20% -$58.5K 0.12% 180
2025
Q3 		$302K Sell
1,305
-12
-0.9% -$2.44K 0.15% 143
2025
Q2 		$254K Sell
1,317
-109
-8% -$20.3K 0.14% 165
2025
Q1 		$299K Sell
1,426
-34
-2% -$6.61K 0.18% 128
2024
Q4 		$249K Buy
1,460
+273
+23% +$50.2K 0.14% 149
2024
Q3 		$235K Buy
+1,187
New +$222K 0.14% 134
2023
Q1 		– Sell
-1,295
Closed -$209K – 145
2022
Q4 		$209K Buy
+1,295
New +$199K 0.19% 124
2022
Q3 		– Sell
-1,391
Closed -$213K – 133
2022
Q2 		$213K Sell
1,391
-11
-0.8% -$1.68K 0.18% 120
2022
Q1 		$227K Buy
+1,402
New +$204K 0.16% 133
2021
Q3 		– Sell
-3,695
Closed -$432K – 156
2021
Q2 		$432K Buy
3,695
+223
+6% +$25.1K 0.32% 92
2021
Q1 		$373K Sell
3,472
-97
-3% -$10.4K 0.28% 103
2020
Q4 		$382K Buy
3,569
+27
+0.8% +$2.6K 0.32% 96
2020
Q3 		$310K Buy
3,542
+3
+0.1% +$282 0.32% 96
2020
Q2 		$347K Sell
3,539
-346
-9% -$30.5K 0.37% 89
2020
Q1 		$296K Sell
3,885
-1,297
-25% -$110K 0.35% 83
2019
Q4 		$458K Buy
+5,182
New +$430K 0.44% 72

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Square's ABBV Position: Q1 2026 in Review

Capital Square reduced its AbbVie (ABBV) stake by 0.86% in Q1 2026, selling an estimated $2K and leaving 1,039 shares worth $207K. The position accounts for 0.1% of the portfolio, ranked #211.

Capital Square first reported a position in ABBV in Q4 2019 and has held it in 17 quarters since. The position peaked at $458K in Q4 2019. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Capital Square held 1,039 shares of AbbVie worth $207K as of Q1 2026.
  • Capital Square sold 9 AbbVie shares in Q1 2026, an estimated $2K.
  • AbbVie made up 0.1% of Capital Square's portfolio in Q1 2026, its #211 holding.
  • Capital Square first reported a position in AbbVie in Q4 2019 and has held it in 17 quarters since.
  • Capital Square's AbbVie position peaked at $458K in Q4 2019.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Capital Square's 13F filing for Q1 2026, filed 11 May 2026.